{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:58:27Z","timestamp":1784033907901,"version":"3.55.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.crohns.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T15:12:28Z","timestamp":1409152348000},"page":"1693-1701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Combination therapy with an immunomodulator and anti-TNF\u03b1 agent improves bone mineral density in IBD patients"],"prefix":"10.1093","volume":"8","author":[{"given":"Anna","family":"Krajcovicova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Hlavaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"Killinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Miznerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Letkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Nevidanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cierny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Zelinkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Huorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Payer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"2","key":"10.1016\/j.crohns.2014.08.004_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med"},{"issue":"44","key":"10.1016\/j.crohns.2014.08.004_bb0010","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.3748\/wjg.15.5517","article-title":"Rheumatic manifestations of inflammatory bowel disease","volume":"15","author":"Rodr\u00edguez-Reyna","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.crohns.2014.08.004_bb0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.crohns.2014.08.004_bb0025","first-page":"43","article-title":"Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort","volume":"232","author":"Schoon","year":"2000","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0030","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.4081\/es.2011.e3","article-title":"Bone loss in inflammatory bowel disease: our multicentric study","volume":"1","author":"Geraci","year":"2011","journal-title":"Endocrinol Stud"},{"issue":"10","key":"10.1016\/j.crohns.2014.08.004_bb0035","first-page":"901","article-title":"Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients","volume":"27","author":"Boubaker","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"issue":"8","key":"10.1016\/j.crohns.2014.08.004_bb0040","first-page":"439","article-title":"The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease","volume":"114","author":"Miznerova","year":"2012","journal-title":"Bratisl Lek Listy"},{"issue":"10","key":"10.1016\/j.crohns.2014.08.004_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.crohns.2014.08.004_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/gast.2002.34779","article-title":"Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County","volume":"123","author":"Loftus","year":"2002","journal-title":"Minn Gastroenterol"},{"issue":"8","key":"10.1016\/j.crohns.2014.08.004_bb0055","first-page":"506","article-title":"Osteoporosis and gastrointestinal disease","volume":"6","author":"Katz","year":"2010","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.crohns.2014.08.004_bb0060","doi-asserted-by":"crossref","first-page":"G191","DOI":"10.1152\/ajpgi.00496.2010","article-title":"Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases","volume":"300","author":"Ghishan","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl. 1","key":"10.1016\/j.crohns.2014.08.004_bb0065","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.crohns.2014.08.004_bb0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","article-title":"AGA technical review on osteoporosis in gastrointestinal diseases","volume":"124","author":"Bernstein","year":"2003","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.crohns.2014.08.004_bb0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00042737-200312000-00003","article-title":"Bone density improves with disease remission in patients with inflammatory bowel disease","volume":"15","author":"Reffitt","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl. A","key":"10.1016\/j.crohns.2014.08.004_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crohns.2014.08.004_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00054725-200203000-00003","article-title":"Risk factors for low bone density in Crohn's disease","volume":"8","author":"Habtezion","year":"2002","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2014.08.004_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1756-185X.2010.01542.x","article-title":"The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases","volume":"13","author":"Ezzat","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohn's Colitis"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024","article-title":"Efficacy and safety of medical therapy for Low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review","volume":"12","author":"Melek","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.crohns.2014.08.004_bb0105","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/me.2009-0069","article-title":"Minireview: live and let die: molecular effects of glucocorticoids on bone cells","volume":"23","author":"Hofbauer","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000092013","article-title":"Analysis of risk factors for low bone mineral density in inflammatory bowel disease","volume":"73","author":"Frei","year":"2009","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.crohns.2014.08.004_bb0115","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1210\/jc.2013-1332","article-title":"Prevalence and predictors of low bone mineral density in males with ulcerative colitis","volume":"98","author":"Khan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.crohns.2014.08.004_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"10.1016\/j.crohns.2014.08.004_bb0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL\u20106 prevents bone loss in ovariectomized mice","volume":"12","author":"Kimble","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.crohns.2014.08.004_bb0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ibd.20039","article-title":"Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease","volume":"13","author":"Paganelli","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.crohns.2014.08.004_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.mcg.0000190762.80615.d4","article-title":"Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease","volume":"40","author":"Abreu","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"15","key":"10.1016\/j.crohns.2014.08.004_bb0140","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.crohns.2014.08.004_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","article-title":"Clinical trial: vitamin D3 treatment in Crohn's disease\u2014a randomized double\u2010blind placebo\u2010controlled study","volume":"32","author":"J\u00f8rgensen","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.crohns.2014.08.004_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03009740802419081","article-title":"The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency","volume":"38","author":"Leventis","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.crohns.2014.08.004_bb0155","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2005.50219.x","article-title":"Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease","volume":"100","author":"Bernstein","year":"2005","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S187399461400227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S187399461400227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T15:28:15Z","timestamp":1498145295000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2014.08.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S187399461400227X"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2014.08.004","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with an immunomodulator and anti-TNF\u03b1 agent improves bone mineral density in IBD patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}